Learn More
Medchemexpress LLC (R)-Lisofylline | 100324-81-0 | 99.99% | 280.32 | 1 ML

Supplier: Medchemexpress LLC HY109854A100MG
(R)-Lisofylline is the (R)-enantiomer of a Pentoxifylline metabolite with anti-inflammatory properties. It acts as a lysophosphatidic acid acyltransferase inhibitor with an IC50 of 0.6 μM and disrupts IL-12 signaling-mediated STAT4 activation. It has potential for research in type 1 diabetes and autoimmune disorders.
- Acts as a lysophosphatidic acid acyltransferase inhibitor.
- Interrupts IL-12 signaling-mediated STAT4 activation.
- Blocks IL-12-driven Th1 differentiation and T cell proliferation.
- Reduces impairment of insulin secretion induced by IL-1β.
- Suppresses IFN-γ production and onset of diabetes in NOD mice.
- Ameliorates experimental allergic encephalomyelitis in mice.
- Improves survival in mice injected with a lethal dose of LPS.
- Ameliorates sepsis-induced lung injury in minipigs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.